Syncope resident survival guide

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karol Gema Hernandez, M.D. [2]; Alejandro Lemor, M.D. [3]

Overview

Syncope is the transient loss of consciousness (LOC) due to cerebral hypoperfusion and it is characterized by a rapid onset, a short duration and a spontaneous complete recovery.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Management

Diagnostic and Treatment Flowchart in Patients with Suspected Syncope

Algorithms based in 2009 ESC Guidelines for the Diagnosis and Management of Syncope. [3]

 
 
 
 
 
Characterize symptoms

Loss of consciousness (LOC)

❑ Rapid onset
❑ Short duration
❑ Spontaneous complete recovery

❑ Prodrome (diaphoresis, nausea, blurry vision)
Chest pain
Palpitations
❑ Bowel or bladder incontinence
❑ Activity prior to LOC (driving, machine operation, flying, competitive athletics)
❑ Position prior to LOC

Supine
❑ Sitting
❑ Standing

Inquire about medications intake:

Nitrate DiureticsAntiarrhythmic
Alpha blocker Beta blocker ACE inhibitors or ARB
Hydralazine EthanolBenzodiazepines
Antipsychotics Tricyclic antidepressants Barbiturates

Inquire about the past medical history:
❑ Previously healthy
❑ Previous syncope episodes
❑ Cardiovascular disease (arrhythmia, valvular disease, heart failure)
❑ Neurological diseases

❑ Recent trauma
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Identify possible triggers:
Emotional stress ❑ Change in positionFatigue
Exertion Warm weather ❑ Prolonged standing
Cough MicturitionDefecation
Swallowing ❑ Head motion ❑ Arm motion
❑ Shaving Trauma
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rule out other possible diagnoses:

With loss of consciousness:
Coma
Sudden cardiac arrest
Epilepsy

❑ Perform neurological evaluation
❑ Perform tilt testing, preferably with concurrent EEG
and video monitoring if doubt of mimicking epilepsy

❑ Metabolic disorders:

Hypoglycemia
Hypoxia
Hyperventilation with hypocapnia

Intoxication
❑ Vertebrobasilar TIA


Without loss of consciousness:
Cataplexy
❑ Drop attacks
❑ Functional /psychogenic pseudosyncope
TIA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Examine the patient
Heart rate
❑ Blood pressure: look for orthostatic hypotension
❑ Cardiac examination: look for palpitations, bruits, murmurs
❑ Neurological examination: look for focal abnormalities (could indicate a cerebrovascular accident)
Order EKG
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reflex
 
Orthostatic hypotension
 
Cardiovascular
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Findings:
Heart rate: tachycardia, normal or bradycardia
❑ Absence of heart disease
❑ History of recurrent syncope
❑ After unpleasant sight or smell
❑ Associated to nausea
❑ Head rotation or pressure to carotid sinsus
❑ Neurological system: look for focal abnormalities
 
Findings:
❑ Blood pressure:
❑ Measure in both arms, while standing and supine
❑ Fall in systolic BP ≥ 20 mmHg and/or in diastolic BP of at least≥ 10 mmHg between the supine and sitting BP reading
❑ Heart rate: tachycardia
❑ Cardiac evaluation: palpitations
❑ After standing up or prolonged standing
❑ Start of new vasodepresive drug
❑ Presence of autonomic neuropathy
 
Findings:
❑ Heart rate: tachycardia, normal or bradycardia
❑ Cardiac evaluation: palpitations, carotid bruits
❑ Presence of structural hearth disease
❑ During exertion
Abnormal EKG findings:
❑ Bifascicular block, Wide QRS(≥ 0.12 s)
Mobitz I second degree AV block
❑ Non-sustained VT , Early repolarization
❑ Pre-excited QRS complexes
❑ Long or short QT intervals
❑ Q waves (myocardial infarction)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment
❑ Explain diagnosis, provide reassurance
❑ Explain risk of recurrence and avoidance of triggers
❑ Isometric PCM in patients with prodrome
 
Treatment
❑ Adequate hydration and salt intake
Midodrine or fludrocortisone as adjunctive therapy if needed
 
Treatment (depends on the cause of the arrhythmia):
Cardiac pacing: for sinus node disease, Mobitz II AV block, BBB with positive EPS
Catheter ablation: for SVT and VT in absence of structural hearth disease
Antiarrhythmic drug therapy: for AF, failed catheter ablation
❑ Implantable cardioverter defibrillator: VT with heart disease, EPS induced VT in patients with previous MI, VT and inherited cardiomyopathy
 
 

Do's

  • Tilt testing is indicated when it is of clinical value to demonstrate susceptibility to reflex syncope to the patient.
  • Tilt testing should be considered to discriminate between reflex and OH syncope.
  • Perform tilt testing if psychiatric disease.
  • Tilt testing may be considered for differentiating syncope with jerking movements from epilepsy.
  • If syncope happened after standing up position, there should be documentation with active standing or tilt testing in order to diagnose OH.
  • Perform CSM if patient >40 years with syncope of unknown aetiology after initial evaluation.
  • If multiple unexplained falls; perform tilt testing.
  • Consider ILR before embarking on cardiac pacing in patients with suspected or certain reflex syncope presenting with frequent or traumatic syncopal episodes.
  • Evaluate neurologically if syncope is due to ANF, to evaluate underlying disease.

Don'ts

  • Don't perform carotid sinus massage (CSM) in patients with previous TIA or stroke within the past 3 months and in patients with carotid sinus bruits (except if carotid sinus Doppler studies excluded significant stenosis.
  • Don't use tilt testing for assessment of treatment.
  • Don't perform isoproterenol tilt testing in patients with ischaemic heart disease.
  • Don't use ATP test as a diagnostic test to select patients for cardiac pacing, owing to lack of correlation with spontaneous syncope,.
  • Don't perform EPS if there is already indication for ICD in patients with ischemic heart with suspected arrhythmic cause.
  • Don't perform EPS in patients with normal ECK, no heart disease, and no palpitations.

References

  1. Khoo, C.; Chakrabarti, S.; Arbour, L.; Krahn, AD. (2013). "Recognizing life-threatening causes of syncope". Cardiol Clin. 31 (1): 51–66. doi:10.1016/j.ccl.2012.10.005. PMID 23217687. Unknown parameter |month= ignored (help)
  2. Kapoor, WN. (2000). "Syncope". N Engl J Med. 343 (25): 1856–62. doi:10.1056/NEJM200012213432507. PMID 11117979. Unknown parameter |month= ignored (help)
  3. Task Force for the Diagnosis and Management of Syncope. European Society of Cardiology (ESC). European Heart Rhythm Association (EHRA). Heart Failure Association (HFA). Heart Rhythm Society (HRS). Moya A; et al. (2009). "Guidelines for the diagnosis and management of syncope (version 2009)". Eur Heart J. 30 (21): 2631–71. doi:10.1093/eurheartj/ehp298. PMC 3295536. PMID 19713422‎ Check |pmid= value (help).